Search
English
RSS

New Items

Picture of HPV 9 in 1 Vaccine (2 Doses) (Suitable for aged 9-14)

HPV 9 in 1 Vaccine (2 Doses) (Suitable for aged 9-14)

Cervical cancer develops in a woman’s cervix, and almost all related cancer cases are linked to HPV infection. Different genotypes of HPV will lead to diverse diseases, including genital warts (for men and women). Some studies advised that nearly 80% sexually active people will face the threats of HPV infection in their lifetime. HPV infection could incur no significant symptoms, and HPV transmission cannot be avoided even using condoms. HPV Vaccine is prophylactic vaccine that could protect men and women aged 15 or above against HPV infection, allowing the immune system to develop HPV antibodies.

  • Suitable Age:9-14 years old
  • HK$2,780.00
    Picture of Comirnaty Bivalent Vaccine

    Comirnaty Bivalent Vaccine

    「復必泰二價疫苗」適用於預防2019 冠狀病毒病,主要針對Omicron變異病毒株所研發的疫苗加強劑。與原始株疫苗相比,具有更好的免疫原性,對身體作更全面的保護。根據BioNTech早前公佈臨床試驗數據,「復必泰二價疫苗」作為加強劑接種有利於加強對老年人群體的保護,加強接種後1個月的數據顯示,18-55歲成年人的中和抗體提高9.5倍,55歲以上老年人的中和抗體提高13.2倍,能夠提供更好的保護效果。

  • 適用對象:年滿18歲及已接種兩劑新冠滅活疫苗人士
  • *如核酸或抗原檢測結果曾呈陽性人士,也可以在以最後一次檢測陽性起計三至六個月後接種
  • 二人或以上優惠(HK$ 1,388/針),如欲了解詳情,請聯絡客戶服務熱線:22728222
  • HK$1,488.00
    Picture of AI Retinal Health Assessment

    AI Retinal Health Assessment

    眼底是眼球內後部的組織,包括視網膜、視盤和視網膜動靜脈血管,眼底異常是導致失明的重要因素。通過AI視網膜健康風險評估,不僅能了解眼底健康,同時能夠發現可能存在的糖尿病、高血壓、心腦血管等慢性疾病風險,提防隱形殺手。1張眼底照片能評估健康風險,快速發現疾病隱患和視網膜異常。早發現 ‧ 早診斷 ‧ 早預防!
    HK$988.00 HK$488.00
    Picture of 2023 CNY Health Check Up Plan

    2023 CNY Health Check Up Plan

    On behalf of MediFast (Hong Kong), we wish you great fortune, prosperity and good health in the coming year. As being told that “Health is Wealth”, it is essential to perform regular health screening and follow-up closer with the health conditions.
    HK$1,250.00 HK$498.00
    Picture of Quadrivalent Recombinant  Influenza Vaccine (Flublok®)

    Quadrivalent Recombinant Influenza Vaccine (Flublok®)

    Seasonal influenza is an acute illness of the respiratory tract caused by influenza viruses. Influenza occurs in Hong Kong throughout the year but is usually more common in periods from January to March / April and from July to August. It is advised to be vaccinated in autumn.

    It takes about two weeks after vaccination to develop antibody and provide prior protection. COVID-19 vaccines can be co-administered with Influenza vaccine, it also can lower possibility of serious complications and death brought from co-infection by influenza and COVID-19.

    Quadrivalent Recombinant Influenza Vaccine is a recombinant-based quadrivalent influenza vaccines produced by Flublok®. It is suitable for any individual aged 18 years or above. For adults aged 50+, it provides 30% better protection and contain 3 times the amount of HA compared with the traditional influenza vaccines.
    HK$495.00
    Picture of Quadrivalent Influenza Vaccine

    Quadrivalent Influenza Vaccine

    Seasonal influenza is an acute illness of the respiratory tract caused by influenza viruses. Influenza occurs in Hong Kong throughout the year but is usually more common in periods from January to March / April and from July to August. It is advised to be vaccinated in autumn.

    It takes about two weeks after vaccination to develop antibody and provide prior protection. COVID-19 vaccines can be co-administered with Influenza vaccine, it also can lower possibility of serious complications and death brought from co-infection by influenza and COVID-19.
    HK$300.00
    Picture of Omicron Neutralizing Antibody Screening

    Omicron Neutralizing Antibody Screening

    With the rampant COVID-19 epidemic situation still raging, Omicron subvariants BA.4 and BA.5 drive surge in cases and become the main COVID strain in HK. Through the Omicron Neutralizing Antibody Screening, you can better understand if there is an immune response after vaccination, whether you may have previously been infected by Omicron BA.1 BA.2 & BA.4/BA.5, and/or have adequate protection antibodies including neutralizing antibodies against future infection.
    HK$660.00 HK$480.00
    Picture of Abbott Panbio COVID-19 Antigen Self-Test (10 Individual Tests)

    Abbott Panbio COVID-19 Antigen Self-Test (10 Individual Tests)

    The Panbio™ COVID-19 Antigen Self-Test is a single-use, in vitro (i.e. outside the body) visually read rapid immunoassay that uses a nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen (Ag). The Panbio™ COVID-19 Antigen Self-Test is intended to be used manually by users for self-testing in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. Children under 14 years should be supported by an adult.

  • HK$399/ 10 Packs
  • Free Shipping
  • Expiry Date: January 2024
  • HK$399.00
    Picture of Post COVID-19 Recovery Health Assessment (Advanced Plan)

    Post COVID-19 Recovery Health Assessment (Advanced Plan)

    The COVID-19 epidemic is still rampant across the globe, as of 13 June 2022, over 532 million cases have been reported worldwide, and 1.22 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Advanced Plan) has been launched which included all health check-up items of “Essential Plan”, also covered COVID-19 antibody test, resting ECG, ultrasound screening and ferritin test, offering comprehensive and holistic care for the recovered persons.
    HK$4,380.00 HK$2,899.00
    Picture of Post COVID-19 Recovery Health Assessment (Essential Plan)

    Post COVID-19 Recovery Health Assessment (Essential Plan)

    The COVID-19 epidemic is still rampant across the globe, as of 13 June 2022, over 532 million cases have been reported worldwide, and 1.22 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Essential Plan) has been launched which incorporates the examination of inflammation, chest X-Ray, liver and renal function for understanding the health status better.
    HK$1,580.00 HK$899.00